Qynapse
A French medical technology company specializing in AI-based brain MRI analysis for CNS clinical trials.
Qynapse Official WebsiteQynapse is a Paris-based medical technology company founded around 2015 by CEO Matias Gómez and neurologist Prof. Marie Sarazin. The company operates at the intersection of AI, medical imaging, and central-nervous-system (CNS) medicine.
The company's flagship product, Qynapse Connect, is a SaaS platform that combines AI-based image analysis with regulated medical device components. It processes brain MRI data to generate quantitative imaging biomarkers for neurodegenerative diseases, specifically Alzheimer's and Parkinson's.
Qynapse primarily serves pharmaceutical and biotech companies conducting CNS clinical trials, acting as an imaging-specialist partner. They provide centralized image reading, quality control, and quantitative analysis to support regulatory submissions and trial endpoints. The company has reportedly pursued ISO 13485 certification and regulatory clearances such as FDA 510(k) and CE marking.